CANCER IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS IS ASSOCIATED WITH IMMUNE-MEDIATED REACTIONS- A PHARMACOVIGILANCE STUDY
Author(s)
Ali AK
Eli Lilly and Company, Indianapolis, IN, USA
OBJECTIVES:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PCN2
Topic
Epidemiology & Public Health
Topic Subcategory
Safety & Pharmacoepidemiology
Disease
Oncology
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now